SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001140361-17-010657
Filing Date
2017-03-06
Accepted
2017-03-06 07:00:19
Documents
3
Period of Report
2017-03-06
Items
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 ONCOCYTE CORP 8-K 3-6-2017 form8k.htm 8-K 19170
2 EXHIBIT 99.1 ex99_1.htm EX-99.1 15976
3 image0.jpg GRAPHIC 38921
  Complete submission text file 0001140361-17-010657.txt   89953
Mailing Address 1010 ATLANTIC AVENUE SUITE 102 ALAMEDA CA 94501
Business Address 1010 ATLANTIC AVENUE SUITE 102 ALAMEDA CA 94501 510-775-0515
OncoCyte Corp (Filer) CIK: 0001642380 (see all company filings)

IRS No.: 271041563 | State of Incorp.: CA | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37648 | Film No.: 17666454
SIC: 2835 In Vitro & In Vivo Diagnostic Substances